Aurobindo Pharma has informed that the board of directors of the company at its meeting held on August 25, 2012, have approved the proposal of appointment of P. V. Ramprasad Reddy as executive chairman of Aurobindo Pharma USA, Inc., the wholly owned subsidiary of the company with effect from December 01, 2012. The said proposal is subject to further approval of the shareholders of the company. Accordingly, an extra ordinary general meeting of the company is being convened on September 27, 2012.
Consequent to his proposed appointment in the company's US subsidiary, the board has also approved Ramprasad Reddy relinquishing the executive responsibilities as whole time director of the company and his continuation as a non-executive director of the company not liable to retire by rotation with effect from December 01, 2012.
The above information is a part of company's filings submitted to BSE.